An Integrated Digital Pathology Platform for Tumors Using Artificial Intelligence Analysis
Changjiang Zhou,Xiaobing Feng,Hongbin Cai,Yi Jin,Harvest F. Gu,Youcai Zhao,Xiaodong Teng,Lingchuan Guo,Jiatong Ji,Shuopeng Jia,Yan Xing,Xiangshan Fan,Jun Liao
DOI: https://doi.org/10.2139/ssrn.3935673
2021-01-01
SSRN Electronic Journal
Abstract:Background: This study aimed to develop a pathologist-annotated and artificial intelligence (AI)-empowered platform for integration and analysis of whole-slide images (WSIs) data and molecular detection data in tumors, which is called PAI-WSIT2.0 (http://www.paiwsit.com).Methods: The standardized data collection process was used for data collection in PAI-WSIT2.0, and in combination, a multifunctional annotation tool was developed and a user-friendly search engine and a web interface were integrated for database accessing. Furthermore, deep learning frameworks were applied in two tasks to detect malignant regions and classify phenotypic subtypes in colorectal cancers (CRCs), respectively.Findings: PAI-WSIT2.0 recorded 8633 WSIs of 1772 tumor cases in total, of which, emphasis was put on the WSIs for CRCs from four regional hospitals in China which dominated in the records and The Cancer Genome Atlas (TCGA), others were WSIs for cancers in breast, lung, prostate, bladder, and kidneys from two Chinese hospitals. A total of 1298 WSIs with high-quality annotations were evaluated by a panel of 8 pathologists. Molecular-level information including immunohistochemistry and gene detection reports of 582 tumor cases were collected. Clinical information of all tumor cases was documented. Besides, we reached an overall accuracy of 0.933 in WSI classification for malignant region detection of CRC, and an area under curves (AUC) value of 0.719 on colorectal subtype dataset.Interpretation: Collectively, the clinical data curation, annotation function, and AI analysis of PAI-WSIT2.0 may serve as an excellent source for WSI analysis researchers and pathologists, providing the clinical support for related computational pathology tasks.Funding: This work was financially supported by the Double-Class University project (CPU2018GY19), the National Natural Science Foundation of China (81473274), and the Postgraduate Research & Practice Innovation Program of Jiangsu Province (KYCX_19_0667). This study was supported by the High-Performance Computing Center, China Pharmaceutical University.Declaration of Interest: The authors declare that they have no conflict of interests.Ethical Approval: The study protocol was approved by the Ethical Committee of Nanjing First Hospital, the First Affiliated Hospital of Zhejiang University, the First Affiliated Hospital of Soochow University, and Nanjing Drum Tower Hospital